iBio, Inc. (IBIO)
2025-06-30 | ||||
---|---|---|---|---|
Revenue | 400 | |||
Research and development | 8,312 | |||
General and administrative | 10,690 | |||
Total operating expenses | 19,002 | |||
Operating loss | -18,602 | |||
Interest income | 437 | |||
Interest expense | 212 | |||
Total other income | 225 | |||
Net loss from continuing operations | -18,377 | |||
Net loss | -18,377 | |||
Earnings per share, basic | -1.75 | |||
Earnings per share, diluted | -1.75 | |||
Weighted average number of shares outstanding, basic | 10,499,000 | |||
Weighted average number of shares outstanding, diluted | 10,499,000 |